Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ISRCTN12857535) titled 'Phase I Trial: Quotient Code QSC301409' on Aug. 20.
Study Type: Interventional
Study Design:
Absorption metabolism distribution and elimination (ADME) study (Other)
Primary Sponsor: Shionogi B.V.
Condition:
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Other
Intervention:
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study reco...